Cargando…
DNA hypomethylation mediates immune response in pan-cancer
Abnormal DNA methylation is a fundamental characterization of epigenetics in cancer. Here we demonstrate that aberrant DNA methylating can modulate the tumour immune microenvironment in 16 cancer types. Differential DNA methylation in promoter region can regulate the transcriptomic pattern of immune...
Autores principales: | Zhang, Chunlong, Sheng, Qi, Zhao, Ning, Huang, Shan, Zhao, Yuming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038033/ https://www.ncbi.nlm.nih.gov/pubmed/36945884 http://dx.doi.org/10.1080/15592294.2023.2192894 |
Ejemplares similares
-
Global DNA hypomethylation in leukocytes associated with glioma risk
por: Shen, Jie, et al.
Publicado: (2017) -
TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer
por: Yokoyama, Seiya, et al.
Publicado: (2017) -
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers
por: Desai, Shruti, et al.
Publicado: (2013) -
Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data
por: Zhao, Ning, et al.
Publicado: (2020) -
DNA hypomethylation silences antitumor immune genes in early prostate cancer and CTCs
por: Guo, Hongshan, et al.
Publicado: (2023)